China Shineway Pharmaceutical Group Limited (C1S.F)

1,0900 +0,0100 (+0,93%) Börsenschluss: 03:29PM CEST

China Shineway Pharmaceutical Group Limited

No. 168, Shiluan Street
Luan Cheng District
Shijiazhuang 051430
China
86 31 1880 30066
https://www.shineway.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Zhenjiang Li	Co-Founder & Executive Chairman	574,63k	N/A	1955
Ms. Yunxia Xin	Co-Founder & Executive Director	401,08k	N/A	1963
Mr. Huimin Li	Executive Director	268,89k	N/A	1968
Mr. Bun Ching Lee	Financial Controller & Company Secretary	N/A	N/A	1973
Mr. King Kuen Hung	Director of Investor Relation	4,25k	N/A	1966
Mr. Yudong Zhang	General Manager of Sales & Marketing	N/A	N/A	1974

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd.

Corporate Governance

China Shineway Pharmaceutical Group Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.